Table 3.

Comparison of diagnostic power of the prediction model with 6TAAs for different stage of GC.

	Training cohort			Validation cohort
Stage	N	Positive (%)	P	N	Positive (%)	P
Early-stage(I-II)	98	66 (67.34)	0.680	73	55 (75.34)	0.560
Late-stage (III-IV)	110	77 (70.00)		82	65 (78.31)

6 TAAs: p62,c-Myc, NPM1, 14-3-3ξ, MDM2 and p16.